Raymond James again expanded its healthcare investment banking practice with the addition of three senior bankers. Joining the firm as managing directors are Jeff Saxton, Matt Pangia and Kevin Carpenter.
All three are seasoned investment bankers with at least 15 years of healthcare investment banking experience. Raymond James has added eight senior bankers in the past six months to healthcare banking.
“Having worked with each of them at previous firms, I have seen firsthand their ability to provide in-depth strategic advice to clients in their respective areas of focus in the healthcare industry,” Doug Brown, senior managing director and head of healthcare investment banking for Raymond James, said in a statement.
“We are focused on delivering thoughtful talented sector specialists to our client base and the addition of Jeff, Matt and Kevin allows us to serve a broader universe of companies in the healthcare industry and we will continue to grow our practice by attracting sector specialists,” he added.
Mr. Saxton joins Raymond James from Lazard’s healthcare team and will serve clients in the healthcare services sector, which includes risk-bearing providers, value-based care enablement, health plans and pharmacy benefits management.
Mr. Pangia covers the medical products industry, including medical device outsourcing, contract manufacturing, automation, medical consumables and other areas within the medical technology supply chain. He comes to Raymond James from SVB.
Mr. Carpenter specializes in healthcare technology, including digital health, consumerism, data exchange and analytics, healthcare payments, benefits technology, payor and provider technology-enabled services and software, and brings over 20 years of healthcare experience as both an investment banker and corporate executive. He joins Raymond James from Zelis, a healthcare payments platform.
